🔥Telegram İfşa

🚨On (or about to be on) the academic job market? Check out our info session + Q&A about zoom interviews tomorrow @ 12pm PST/3pm EST! 👇

Wonderful news!!! Congratulations Lorenz !

Investigaciones impresionantes con una -potencial- esperanza para los pacientes con enfermedad de #Hirschsprung (c) Faranak Fattahi y su equipo

Choose your cells' path wisely—early life experiences could lead to a personality crisis! Check out our new preprint by Nick Elder et al. biorxiv.org/content/10.110…

𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗶𝗻𝗴 Shark Tooth Biotech: 𝗔 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹 𝗠𝗶𝘀𝘀𝗶𝗼𝗻 𝘁𝗼 𝗖𝗼𝗺𝗯𝗮𝘁 𝗖𝗠𝗧𝟭𝗔 2 years ago, my world was flipped upside down. My 2-year-old son, Ari, was diagnosed with Charcot-Marie-Tooth Disease Type 1A (CMT1A). 🧵

Our true labor of love was published at Gastroenterology!! We showed: increased risk for the DGBI, functional constipation-matching our findings in Molecular Psychiatry and( 2) the gut may be a more targeted way to treat anxiety and depression! pubmed.ncbi.nlm.nih.gov/39658704/

Excited to announce my new lab at MCDB Michigan opening Jan 2025! 🎉 We’ll study how cells work together to shape the GI tract, with ties to regeneration & disease. Hiring at all levels—esp. a research tech to help launch the lab! Info: huyckelab.org #DevBio #CellBio

Our latest from the indefatigable Johnny Yu in collaboration with Jonathan Weissman's Lab and Kevan Shokat. Meet GENEVA, which enables simultaneous phenotyping and profiling of cancer cell drug responses at scale; both in vitro and in vivo across a variety of models: biorxiv.org/content/10.110…

If you're interested in small non-coding RNAs (smRNAs) and their gene regulatory functions, with Hani Goodarzi we have something exciting for you: Decoy-seq, a new method to profile, at scale, transcriptional responses to perturbations of smRNAs: biorxiv.org/content/10.110… (1/n)

A nice clear explanation of how scientific breakthroughs require infrastructure. A quote: The Council on Governmental Relations… stated that “America’s competitors will relish this self-inflicted wound.” theconversation.com/how-much-does-…

So excited about this paper! Congratulations to all authors! Enteric glutamatergic interneurons regulate intestinal motility: Neuron cell.com/neuron/fulltex…

Nothing to see here MAGA, just science casually treating hearing loss investor.regeneron.com/news-releases/…

When women scientists connect and lead, the whole field moves forward. UCSF Pathology's Carolyn Sangokoya saw a gap and built Women Physician-Scientists at UCSF to change that. Through mentorship and collaboration, she’s creating a stronger future for women in science. tiny.ucsf.edu/m4DOTy

R&D FTW forbes.com/sites/michaelt…

The Moslehi laboratory is recruiting a post-doctoral fellow with a PhD in immunology or molecular biology. See below! nature.com/naturecareers/… Below information about the lab: cardiooncologylab.ucsf.edu Interested candidates can email me with CV! [email protected]

Thank you, Madhu! Grateful for the opportunity to visit you and your incredible colleagues at Mayo Clinic Gastroenterology & Hepatology. Truly inspired by the outstanding science and exciting discussions!

Check out our new preprint by the amazing Mona Khalaj et al!

Joining forces with Babak Alipanahi, Hormozdiari Lab, Aiden M Sababi & Mehran Karimzadeh to bring you Exai-1; a multi-modal cell-free RNA foundation model for blood surveillance and liquid biopsy. Kudos to the broader exai bio team for getting this across the line. biorxiv.org/content/10.110…

Dr. Viviane Tabar and Dr. Lorenz, physician-scientists at MSK, have developed a treatment for #Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them into patients. Early results show the treatment is safe and may improve

Early results from an MSK study shows a treatment for #Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them into patients is safe and may improve Parkinson’s symptoms. Read more via NPR: n.pr/43ZW1v6